Study Shows Pembrolizumab Active in Relapsed Refractory Populations - 101931

Spotlight
Video

Study Shows Pembrolizumab Active in Relapsed Refractory Populations

ASHReport has 256 videos Subscribe Here

Loading........
Description: Jonathan Gerber, MD of Levine Cancer Institute, gives an overview of a clinical study that shows pembrolizumab is active in relapsed refractory populations of AML at the 58th ASH Annual Meeting in San Diego, CA.
Shared By : ASHReport
Posted on : 12/16/16
Added : 1 year ago